Several groups have determined that Cdc42 might promote hypertrophy in cardiomyocytes [13], whereas Maillet M et al. reported that heart-specific deletion of Cdc42 aggravated TAC-induced cardiac hypertrophy and promoted the transition to heart failure in Cdc42αMHC−Cre mice [15]. Here, CDC42 is linked to cardiac hypertrophy.